News

Battle brews over screening for asymptomatic kidney disease


 

FROM ANNALS OF INTERNAL MEDICINE

Dr. Cooke said the ACP was calling for a "middle ground" to bring the discussion back to what is best for the patient, not the practitioner.

"We are saying that unless the patient has a reason for you to be concerned, other than the fact that they are a human being, there is no reason to screen for CKD every year," she explained. "There is no evidence that diagnosing the average person on the street as stage 1 or 2 [CKD] does them any good if they don’t have any risk factors."

The American College of Physicians funded the guidelines. The guidelines’ authors had no relevant disclosures.

wmcknight@frontlinemedcom.com

Pages

Recommended Reading

FDA okays flutemetamol for color-enhanced amyloid imaging
MDedge Internal Medicine
No-drug approach scores a 35% smoking cessation rate at 1 year in elderly, long-term-care residents
MDedge Internal Medicine
Hypofractionation doesn’t reduce IMRT failure in prostate cancer
MDedge Internal Medicine
ACCORD: Younger, not older, age linked to higher cardiovascular death rates
MDedge Internal Medicine
Regular exercise added to days of perfect health in OA patients
MDedge Internal Medicine
Knee replacement delayed by hyaluronic acid injections
MDedge Internal Medicine
Small study: TBI leads to rapid deposition of brain amyloid
MDedge Internal Medicine
Shingles vaccine most effective and cost effective when given to patients in their 60s
MDedge Internal Medicine
Boceprevir, telaprevir linked to anemia in HCV-infected seniors
MDedge Internal Medicine
Fish oil for dry eyes
MDedge Internal Medicine